About Casimir
Casimir is a Healthcare company based in Plymouth (United States) founded in 2016, and was acquired by Emmes in March 2022. Clinical supply chain services are provided by CRO for trials. Its chief executive, as recorded, is Christine McSherry. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Clario, Lightship and SFJ Pharmaceuticals; 2 of its 3 listed competitors have raised funding.
Company details
Casimir was founded in 2016 in Plymouth, United States, as a contract research organization specializing in clinical supply chain services. Operations are centered on managing logistics and distribution for clinical trials. Services include supply chain optimization, temperature-controlled shipping, and regulatory compliance support. Leadership is provided by CEO Christine McSherry. The company serves the pharmaceutical and biotech sectors across the United States.
- Headquarters Plymouth, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website casimirtrials.com
- Social LinkedIn Facebook
- Acquired by Emmes (Mar 2022)
Investors in Casimir
Casimir has secured backing from 1 investor. Prominent investors backing the company include Emmes.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Outsourced contract research organization services are provided to clients. | 1977 | emmes.com | United States |
Investor details for Casimir
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Casimir
1 people are tracked at Casimir (1 in leadership).
| Name | Role | Group |
|---|---|---|
Christine McSherry | CEO | Leadership |
Complete people profiles for Casimir
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Casimir
2 dated milestones of Casimir across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Casimir is founded.
- Exit Acquired by Emmes.
Competitors of Casimir
Casimir has 3 listed competitors in our database, 2 of them funded. They include Clario, Lightship and SFJ Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clario.com | 1972 | Philadelphia, United States | 11 | CRO focused on providing clinical trial supply services for biopharma sector | ||
| lightship.com | 1995 | El Segundo, United States | $205.55M | 74 | Direct-to-patient clinical trial solutions are provided by Lightship. | |
| sfj-pharma.com | 2008 | Pleasanton, United States | $69.5M | 12 | Specialty pharmaceutical company based on partnering model |
Detailed competitors of Casimir
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Casimir (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Casimir
Complete news archive for Casimir
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Casimir
Casimir was founded in 2016.
Casimir is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Christine McSherry is the CEO of Casimir, as recorded in our data.
Casimir was founded in 2016 in Plymouth, United States, as a contract research organization specializing in clinical supply chain services. Operations are centered on managing logistics and distribution for clinical trials. Services include supply chain optimization, temperature-controlled shipping, and regulatory compliance support. Leadership is provided by CEO Christine McSherry. The company serves the pharmaceutical and biotech sectors across the United States.
Casimir's top competitors include Lightship, SFJ Pharmaceuticals and Clario.
Casimir has 1 investor. Key investors include Emmes.
Yes. Casimir was acquired by Emmes in March 2022.